{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:45:31Z","timestamp":1790696731259,"version":"4.1.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We report the case of a 23-year-old man presenting a right hypersecreting pheochromocytoma, falsely negative on <jats:sup>18<\/jats:sup>F-FDG PET\/CT and on <jats:sup>123<\/jats:sup>I-metaiodobenzylguanidine (<jats:sup>123<\/jats:sup>I-MIBG) scintigraphy but strongly positive on <jats:sup>18<\/jats:sup>F-FDOPA PET\/CT. Functional imaging has a key role in diagnosis and prognosis of pheochromocytomas, but choosing the most relevant modality remains difficult. Despite its high specificity, <jats:sup>123<\/jats:sup>I-MIBG has a limited sensitivity. <jats:sup>18<\/jats:sup>F-FDG can be used, but it is an unspecific tracer, and <jats:sup>18<\/jats:sup>F-FDG uptake in brown adipose tissue can hinder the analysis. However, <jats:sup>18<\/jats:sup>F-FDOPA shows very high sensitivity and specificity in pheochromocytomas with fewer drug interferences than <jats:sup>123<\/jats:sup>I-MIBG.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002736","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T12:13:13Z","timestamp":1563192793000},"page":"738-740","source":"Crossref","is-referenced-by-count":7,"title":["18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Alexandre","family":"Lugat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, l'Institut du Thorax, CHU de Nantes, H\u00f4pital Nord"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Miralli\u00e9","sequence":"additional","affiliation":[{"name":"Digestive and Endocrine Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Kraeber-Bod\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ansquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","year":"2005","journal-title":"Lancet Lond Engl"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2967\/jnumed.106.035915","article-title":"Brown fat imaging with 18F-6-fluorodopamine PET\/CT, 18F-FDG PET\/CT, and 123I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma","volume":"48","year":"2007","journal-title":"J Nucl Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2265.2006.02571.x","article-title":"Phaeochromocytomas presenting as acute crises after beta blockade therapy","volume":"65","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12020-013-0007-y","article-title":"Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features","volume":"45","year":"2014","journal-title":"Endocrine"},{"key":"bib7-20230925","first-page":"1326","article-title":"Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice?","volume":"17","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00259-016-3586-z","article-title":"18F-fluorodihydroxyphenylalanine PET\/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00259-009-1294-7","article-title":"Clinical value of 18F- fluorodihydroxyphenylalanine positron emission tomography\/computed tomography (18F-DOPA PET\/CT) for detecting pheochromocytoma","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/MNM.0000000000000708","article-title":"Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET\/CT: focus on pheochromocytomas","volume":"38","year":"2017","journal-title":"Nucl Med Commun"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/RLU.0b013e31829aface","article-title":"18F-DOPA PET\/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes","volume":"39","year":"2014","journal-title":"Clin Nucl Med"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00259-017-3833-y","article-title":"Quantitative 18F-DOPA PET\/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:14:06Z","timestamp":1695618846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002736","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}